Preinfusion polyfunctional anti-CD19 chimeric antigen receptor T cells are associated with clinical outcomes in NHL

Kochenderfer, 2013, Treating B-cell cancer with T cells expressing anti-CD19 chimeric antigen receptors, Nat Rev Clin Oncol, 10, 267, 10.1038/nrclinonc.2013.46

June, 2014, Engineered T cells for cancer therapy, Cancer Immunol Immunother, 63, 969, 10.1007/s00262-014-1568-1

Sadelain, 2013, The basic principles of chimeric antigen receptor design, Cancer Discov, 3, 388, 10.1158/2159-8290.CD-12-0548

Kochenderfer, 2009, Construction and preclinical evaluation of an anti-CD19 chimeric antigen receptor, J Immunother, 32, 689, 10.1097/CJI.0b013e3181ac6138

Kochenderfer, 2012, B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells, Blood, 119, 2709, 10.1182/blood-2011-10-384388

Kochenderfer, 2017, Lymphoma remissions caused by anti-CD19 chimeric antigen receptor T cells are associated with high serum interleukin-15 levels, J Clin Oncol, 35, 1803, 10.1200/JCO.2016.71.3024

Seder, 2008, T-cell quality in memory and protection: implications for vaccine design [published correction appears in Nat Rev Immunol. 2008;8(6):486], Nat Rev Immunol, 8, 247, 10.1038/nri2274

Ma, 2013, Multifunctional T-cell analyses to study response and progression in adoptive cell transfer immunotherapy, Cancer Discov, 3, 418, 10.1158/2159-8290.CD-12-0383

Lu, 2015, Highly multiplexed profiling of single-cell effector functions reveals deep functional heterogeneity in response to pathogenic ligands, Proc Natl Acad Sci USA, 112, E607, 10.1073/pnas.1416756112

Hamlin, 2003, Age-adjusted International Prognostic Index predicts autologous stem cell transplantation outcome for patients with relapsed or primary refractory diffuse large B-cell lymphoma, Blood, 102, 1989, 10.1182/blood-2002-12-3837

Cheson, 2014, Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification, J Clin Oncol, 32, 3059, 10.1200/JCO.2013.54.8800

Baron, 2007, DNA demethylation in the human FOXP3 locus discriminates regulatory T cells from activated FOXP3(+) conventional T cells, Eur J Immunol, 37, 2378, 10.1002/eji.200737594

Brucklacher-Waldert, 2009, Phenotypical and functional characterization of T helper 17 cells in multiple sclerosis, Brain, 132, 3329, 10.1093/brain/awp289

Wang, 2011, Interleukin-17-secreting T cells in neuromyelitis optica and multiple sclerosis during relapse, J Clin Neurosci, 18, 1313, 10.1016/j.jocn.2011.01.031

Jabri, 2015, IL-15 functions as a danger signal to regulate tissue-resident T cells and tissue destruction, Nat Rev Immunol, 15, 771, 10.1038/nri3919

Waldmann, 2006, The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design, Nat Rev Immunol, 6, 595, 10.1038/nri1901

Turtle, 2016, Immunotherapy of non-Hodgkin’s lymphoma with a defined ratio of CD8+ and CD4+ CD19-specific chimeric antigen receptor-modified T cells, Sci Transl Med, 8, 355ra116, 10.1126/scitranslmed.aaf8621

Porter, 2015, Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia, Sci Transl Med, 7, 303ra139, 10.1126/scitranslmed.aac5415

Teachey, 2016, Identification of predictive biomarkers for cytokine release syndrome after chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia, Cancer Discov, 6, 664, 10.1158/2159-8290.CD-16-0040

Zou, 2010, T(H)17 cells in tumour immunity and immunotherapy [published correction appears in Nat Rev Immunol. 2011;11(8):565], Nat Rev Immunol, 10, 248, 10.1038/nri2742

Harada, 1994, Essential involvement of interleukin-8 (IL-8) in acute inflammation, J Leukoc Biol, 56, 559, 10.1002/jlb.56.5.559

Cook, 1995, Requirement of MIP-1 alpha for an inflammatory response to viral infection, Science, 269, 1583, 10.1126/science.7667639

Dudley, 2010, CD8+ enriched “young” tumor infiltrating lymphocytes can mediate regression of metastatic melanoma, Clin Cancer Res, 16, 6122, 10.1158/1078-0432.CCR-10-1297

Muranski, 2011, Th17 cells are long lived and retain a stem cell-like molecular signature, Immunity, 35, 972, 10.1016/j.immuni.2011.09.019

Chattopadhyay, 2014, Single-cell technologies for monitoring immune systems, Nat Immunol, 15, 128, 10.1038/ni.2796

Xue, 2017, Single-cell multiplexed cytokine profiling of CD19 CAR-T cells reveals a diverse landscape of polyfunctional antigen-specific response, J Immunother Cancer, 5, 85, 10.1186/s40425-017-0293-7